Health News

RSS Feed

Raludotatug Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Recurrent Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer in Phase 2 Part of REJOICE-Ovarian01 Phase 2/3 Trial

7:45 AM on Sunday, October 19

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

6:00 AM on Sunday, October 19

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

1:30 AM on Sunday, October 19

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

9:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

9:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

9:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

9:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

9:30 AM on Saturday, October 18

Music could help ease pain from surgery or illness. Scientists are listening

8:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

1 2 3 4 5 ... Last

Sponsored Links

Trending Videos

Salem News Channel Today

Trending Videos

On Air & Up Next

  • Bloomberg Radio
    3:00PM - 6:00PM
     
    Bloomberg Radio is the world's only global 24-hour business radio station.   >>
     
  • World of Aviation
    6:00PM - 7:00PM
     
    World of Aviation with Al Malmberg brings you the latest in aviation news and technology.
     
  • RMWorldTravel
    7:00PM - 9:00PM
     
    Take flight with America’s #1 Travel Radio Show, RMWorldTravel, hosted by   >>
     
  • The Ramsey Show
    9:00PM - 12:00AM
     
    Millions listen to The Ramsey Show every day for common-sense talk on money.   >>
     
  • Bloomberg Radio
    12:00AM - 1:00AM
     
    Bloomberg Radio is the world's only global 24-hour business radio station.   >>
     

See the Full Program Guide